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Background: This study aimed to determine early postoperative changes of plasma polyunsaturated fatty acids
(PUFAs) following laparoscopic sleeve gastrectomy (LSG).
Methods: Ten obese patients (mean BMI: 51.10 ± 11.59 kg/m2) underwent LSG and eleven normal weight control
patients (mean BMI: 24.37 ± 2.33 kg/m2) underwent laparoscopic abdominal surgery. Fasting blood samples were
collected prior to surgery, at day 1 after surgery and after postoperation oral feeding. Plasma levels of arachidonic acid
(AA, C20:4n6), dihomo-gamma-linolenic acid (DGLA, C20:3n6), eicosapentaenoic acid (EPA, C20:5n3) and docosahexaenoic
acid (DHA, C22:6n3) were determined by an optimized multiple reaction monitoring (MRM) method using ultra fast-liquid
chromatography (UFLC) coupled with tandem mass spectrometry (MS/MS). Prostaglandin E2 (PGE2) was measured in
serum samples by enzyme immunoassay.
Results: A significant decrease was observed in insulin and HOMA IR levels in sleeve gastrectomy patients after
postoperation oral feeding compared to preoperation. Plasma AA levels and AA/EPA ratio were significantly increased in
sleeve gastrectomy patients after postoperation oral feeding compared to postoperation day 1. Serum PGE2 levels and
AA/DHA ratio was significantly higher in sleeve gastrectomy patients at preoperation, postoperation day 1 and after
postoperation oral feeding when compared to control group patients.
Conclusion: Increased peripheral insulin sensitivity associated with LSG may play a role in the significant increase
of plasma AA levels in sleeve gastrectomy patients following postoperation oral feeding. The significant increase
in PGE2 levels and AA/DHA ratio in sleeve gastrectomy group patients also confirms the presence of a
proinflammatory state in obesity.
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The human body can produce many fatty acids except
the two essential polyunsaturated fatty acids (PUFAs)
which include linoleic acid (LA, C18:2n6) and alpha-
linolenic acid (ALA, C18:3n3) [1]. Linoleic acid is the
precursor of omega-6 (n-6) series of PUFAs while ALA
is the precursor of omega-3 (n-3) series of PUFAs [2].
Eicosanoids derived from n-6 PUFAs such as arachi-
donic acid (AA, C20:4n6) have proinflammatory and* Correspondence: mutayaslan@akdeniz.edu.tr
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unless otherwise stated.immunoactive functions, whereas eicosanoids derived
from n-3 PUFAs such as eicosapentaenoic acid (EPA,
C20:5n3) and docosahexaenoic acid (DHA, C22:6n3) have
anti-inflammatory properties, attributed to their ability to
inhibit the formation of n-6 PUFA-derived eicosanoids [3].
Recent studies have documented the presence of an im-
balance in PUFA levels and its correlation with visceral fat
accumulation in male subjects [4]. Moreover, a correlation
between acute phase proteins and serum PUFA compos-
ition was shown in morbidly obese patients [5].
Laparoscopic sleeve gastrectomy (LSG) is associated
with a high rate of resolution of type 2 diabetes mellitus
(T2DM) and other obesity-associated comorbidities such
as hypertension and hyperlipidemia [6]. The improvementtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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LSG with a significant reduction in insulin resistance [7].
Insulin stimulates the conversion of essential fatty acids
(LA and ALA) to longer-chain PUFAs [8]. Indeed, levels
of the principal n-6 PUFA, AA, are reported to be signifi-
cantly lower in diabetic patients than in controls [9,10]. It
was recently shown that insulin analog initiation therapy
significantly increased plasma PUFA levels in patients with
T2DM [11]. Restoration of the first phase of insulin secre-
tion and improved insulin sensitivity in diabetic obese pa-
tients immediately after sleeve gastrectomy, before any
weight loss, seem to be related to hormonal changes of
possible gastric origin and is neither meal- nor weight-
change-related [12]. To our knowledge no study has eval-
uated the effect of LSG on plasma levels of PUFAs. This
study aimed to assess early postoperative effects of LSG




The control group included 11 patients who were admit-
ted to Antalya Research and Education Hospital, Surgery
Clinic. Patients in the control group underwent laparo-
scopic abdominal surgery for appendectomy (n = 5), chole-
cystectomy (n = 4), partial cystectomy (n = 1) and inguinal
hernia repair (n = 1). Subjects with apparent history of
stroke, coronary heart disease, arrhythmia, peripheral ar-
tery disease, severe kidney dysfunction, liver disease, thy-
roid dysfunction, infectious disease were excluded. The
body mass index (BMI) of all patients in the control group
was <30 kg/m2 and all were non-smokers. Fasting blood
samples were obtained from all patients at preoperation,
postoperation day 1 and after postoperation oral feeding.
The sleeve gastrectomy group included 10 obese patients
who were admitted to Antalya Research and Education
Hospital, Endocrinology Clinic. The BMI of all patients in
the sleeve gastrectomy group was ≥40 kg/m2. All patients
went through a clinical, biochemical and pre-anesthetic
evaluation and subjects with apparent history of stroke, cor-
onary heart disease, arrhythmia, peripheral artery disease,
severe kidney dysfunction, liver disease, thyroid dysfunction,
infectious disease were excluded. All patients met the surgi-
cal indication criteria in the inter-disciplinary European
guidelines on surgery of severe obesity [13]. Fasting blood
samples were obtained from all sleeve gastrectomy patients
the day before operation (preoperation), the day after oper-
ation (postoperation day 1) and the day after postoperation
oral feeding. All sleeve gastrectomy patients were on
preoperative diet for 2 weeks, before surgery. This diet con-
tained liquid protein supplements and sugar-free, non-
carbonated, low calorie fluids and required a minimum of 2
liters of fluid intake daily. Female and male patients were
aimed to receive 65 and 80 grams protein daily, respectively.Patients did not receive any food and no fluid by mouth
starting from midnight the day of surgery until the day after
surgery. Patients were tested several times after surgery for
anastomatic leaks. When patients were determined to be
leak free, postoperation oral feeding was initiated by aiming
120 ml per hour fluid intake. Clear bouillon, sugar-free gel-
atin, sugar-free flavored beverages, 1:1 water diluted apple,
cranberry, or grape juice were allowed to be added to the
diet at this stage. Postoperation oral feeding was continued
until the patients were discharged from the hospital. All
sleeve gastrectomy patients and control group subjects gave
written informed consent prior to entry. This study was ap-
proved by the Institutional Review Board for Human Use at
Akdeniz University Faculty of Medicine.
Laboratory measurements
Serum glucose was measured on Roche Cobas 8000 Modu-
lar Analyser (Basel, Switzerland). Insulin levels were mea-
sured by Roche/Hitachi E170 modular analyser (Tokyo,
Japan). Insulin sensitivity was evaluated using homeostatic
model assessment for insulin resistance (HOMA IR) [14].
Electrospray ionization mass spectrometry
Standards for AA (C20:4n6), DGLA (C20:3n6), EPA
(C20:5n3) and DHA (C22:6n3) were purchased from
Sigma-Aldrich (St. Louis MO, USA). Deuterium labeled
AA-d8 internal standard (5,6,8,9,11,12,14,15-AA-d8) was
obtained from Santa Cruz Biotechnology (Santa Cruz, CA,
USA). Solutions of AA, DGLA, EPA, DHA and AA-d8
standards were prepared in analytical grade methanol
(Merck, Darmstadt, Germany). An optimized multiple re-
action monitoring (MRM) method was developed using
ultra-fast liquid chromatography (UFLC) coupled with
tandem mass spectrometry (MS/MS). A UFLC system
(LC-20 AD UFLC XR, Shimadzu Corporation, Japan)
was coupled to a LCMS-8040 triple quadrupole mass
spectrometer (Shimadzu Corporation, Japan). Chromato-
graphic separations were carried out using Inertsil HPLC
column (ODS-4, 2.1 × 100 mm, 3 μm; GL Sciences Inc.
Tokyo, Japan) maintained at 40°C. DHA, EPA, AA and
DGLA were separated using a gradient elution with a flow
rate of 0.45 ml/min. Mobile phase solvent A was 10 mM
ammonium acetate (Sigma-Aldrich, St. Louis, MO, USA) in
water and solvent B was acetonitrile (Sigma-Aldrich, St.
Louis, MO, USA). Gradient program was solvent B, 70%
(0 min), 90% (3 min), 100% (3.01-4 min) and 70% (4.01-
8 min). MRM transitions and responses were automatically
optimized for individual compounds in negative electro-
spray ionization (ESI). In the negative ESI-MS mode
the precursor and product m/z values for AA, DHA,
EPA, DGLA and AA-d8 are given in Table 1. Responses
to AA, DHA, EPA and DGLA were optimized to a lin-
ear calibration range from 100 ng/ml to 30 ug/ml and a
sample analysis time of 8 minutes.
Table 1 The precursor and product m/z values for
analyzed polyunsaturated fatty acids
Precursor m/z Product m/z
DGLA (C20:3n6) 304.80 59.00, 260.70
AA (C20:4n6) 303.10 59.00, 258.90
EPA (C20:5n3) 301.10 59.10, 256.70
DHA (C22:6n3) 327.10 59.10, 283.20
AA-d8 311.10 59.10, 97.90, 267.10
DGLA, dihomo-gamma-linolenic acid; AA, arachidonic acid; EPA,
eicosapentaenoic acid; DHA, docosahexaenoic acid.
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Samples were prepared for LC-MS/MS analysis via a
modified protocol as previously described [15]. Briefly,
in a glass test tube, 200 μl plasma was added to 200 μl
AA-d8 internal standard solution. 1 ml of acetonitril/
37% hydrochloric acid (Cayman, Ann Arbor, MI, USA)
was added to the mixture in a 4:1 v/v. Tubes were
capped with reusable teflon liner screw caps and sam-
ples were hydrolyzed by incubating at 90°C for 2 hours
in a heating block (VLM, Bielefeld, Germany). After
cooling down to room temperature, fatty acids were ex-
tracted with 2 ml of hexane. Samples were vortex-mixed
for 20 seconds, left at room temperature for 5 minutes
and centrifuged at 3000 rpm for 1 minute. The upper
phase containing free fatty acids were transferred to glass
tubes and evaporated at room temperature under a con-
stant stream of nitrogen with height adjustable gas distri-
bution unit (VLM, Bielefeld, Germany). Fatty acids were
dissolved in 200 μl methanol–water (180:20, v/v) filtered
via 0,2 μm polytetrafluoroethylene (PTFE) syringe filters
(Whatman, GE Healthcare Bio-Sciences, Pittsburgh, USA)
and transferred to autosampler vials (Vertical Chromatog-
raphy, Nonthaburi, Thailand).Table 2 Serum glucose, insulin concentration and
HOMA-IR values in control and sleeve gastrectomy group








(n = 10)Measurement of prostaglandin E2
Prostaglandin E2 (PGE2) was measured in serum samples
by a commercial enzyme immunoassay test kit [KGE004B;
R&D Systems, Inc., Minneapolis, MN 55413, USA] accord-
ing to manufacturer’s instructions. A standard curve of ab-
sorbance values of known PGE2 standards was plotted as a
function of the logarithm of PGE2 standard concentrations
(pg/ml) using the GraphPad Prism Software program for
windows version 5,03. (GraphPad Software Inc). PGE2 con-
centrations in the samples were calculated from their corre-
sponding absorbance values via the standard curve.Glucose (mg/dL) 103.0 ± 21.6 96.9 ± 22.7 102.2 ± 26.8 102.5 ± 31.3
Insulin (mU/L) 9.7 ± 9.4 7.7 ± 6.9 18.8 ± 10.2 11.1 ± 6.9*
HOMA-IR 2.7 ± 3.3 2.1 ± 2.9 4.9 ± 3.5 2.9 ± 2.1*
Values are mean ± SD. Preop, preoperation; Postop, postoperation; Po OF,
postoperation oral feeding. *p < 0.01 postoperation oral feeding vs.
preoperation in the sleeve gastrectomy group.Statistical analysis
Data were analyzed using Sigma Stat (version 2.03) stat-
istical software for Windows, and a P value < 0.05 was
considered statistically significant.Results
Control and sleeve gastrectomy group characteristics
The control group was composed mainly of women (7 fe-
male, 4 male). The mean ± SD of age, body weight and
body mass index in the control group was 41 ± 18 years,
65 ± 6 kg and 24.37 ± 2.33 kg/m2, respectively. The sleeve
gastrectomy group was also composed mainly of women
(7 female, 3 male). The mean ± SD of age, body weight,
body mass index, fat mass and lean mass in the sleeve gas-
trectomy group was 38 ± 11 years, 130 ± 22 kg, 51.10 ±
11.59 kg/m2, 67.2 ± 15 kg and 59.7 ± 10.3 kg respectively.
Biochemical measurements
Glucose, insulin and HOMA IR levels from control and
sleeve gastrectomy patients are shown in Table 2. A sig-
nificant decrease was observed in insulin and HOMA IR
levels in sleeve gastrectomy patients after postoperation
oral feeding compared to preoperation. Statistical ana-
lysis was done by Paired t-test.
ESI-MS spectra
Figure 1A shows representative negative ion mode spectra
of a patient sample. As shown in the figure, retention time
of EPA (C20:5n3), DHA (C22:6n3), AA (C20:4n6) and
DGLA (C20:3n6) was 1.869, 2.131, 2.391 and 2.911 minutes,
respectively. Figure 1B shows tandem mass spectra ob-
tained by collision-induced dissociation of precursor ions.
The m/z values of 256.7, 258.9, 260.7, 283.2 product ions
correspond to endogenous C20:5n3, C20:4n6, C20:3n6 and
C22:6n3, respectively. The deuterium-labeled internal
standard fatty acid peaks are indicated at m/z values 97.9
and 267.1.
Levels of polyunsaturated fatty acids
Blood samples obtained from control group patients
showed no significant difference in levels of AA
(C20:4n6), DGLA (C20:3n6), EPA (C20:5n3) and DHA
(C22:6n3) (Table 3). The ratio of DGLA/AA, AA/EPA and
AA/DHA were also similar in control group samples ob-
tained at preoperation, postoperation day 1 and after post-
operation oral feeding. Likewise, DGLA (C20:3n6), EPA
(C20:5n3) and DHA (C22:6n3) serum levels in sleeve
Table 3 Analysis of polyunsaturated fatty acids in control and
postoperation oral feeding
Control group
Variable Preop (n = 11) Postop day 1 (n = 11) Po O
AA (C20:4n6) (μg/ml) 124.0 ± 27.8 110.5 ± 22.8 11
DGLA (C20:3n6) (μg/ml) 45.9 ± 16.4 37.9 ± 13.1 36
EPA (C20:5n3) (μg/ml) 9.1 ± 7.7 7.9 ± 9.4 7
DHA (C22:6n3) (μg/ml) 50.4 ± 13.6 47.4 ± 13.8 51
DGLA/AA 0.38 ± 0.14 0.34 ± 0.11 0.
AA/EPA 23.7 ± 18.1 23.3 ± 12.9 24
AA/DHA 2.64 ± 0.94 2.45 ± 0.65 2.
Values are mean ± SD. Preop, preoperation; Postop, postoperation; Po OF, postoper
EPA, Eicosapentaenoic acid; DHA, Docosahexaenoic acid.
*p = 0.007 postoperation oral feeding vs. postoperation day 1 in the sleeve gastrect
**p < 0.02 postoperation oral feeding vs. preoperation and postoperation day 1 in t









































Figure 1 ESI-MS Spectra. A) Representative negative ion mode
spectra of a patient sample. DGLA, Dihomo-gamma-linolenic acid; AA,
Arachidonic acid; EPA, Eicosapentaenoic acid; DHA, Docosahexaenoic
acid. B) Tandem mass spectra.
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operation day 1 and after postoperation oral feeding. There
was also no significant difference observed in DGLA
(C20:3n6), EPA (C20:5n3) and DHA (C22:6n3) serum
levels between control and sleeve gastrectomy patients
(Table 3). Serum AA (C20:4n6) levels and AA/EPA ratio
were significantly increased in sleeve gastrectomy patients
after postoperation oral feeding compared to postoperation
day 1. Levels of AA (C20:4n6) and AA/EPA ratio were also
significantly higher in sleeve gastrectomy patients after
postoperation oral feeding compared to control group pa-
tients on the same day. AA/DHA ratio was significantly
higher in sleeve gastrectomy patients at preoperation, post-
operation day 1 and after postoperation oral feeding when
compared to control group patients (Table 3). Statistical
analysis was done by Paired t-test or Wilcoxon Signed Rank
Test. Distribution of AA (C20:4n6), DGLA (C20:3n6), EPA
(C20:5n3) and DHA (C22:6n3) in serum samples of control
and sleeve gastrectomy patients are shown in Figure 2.
Prostaglandin E2 levels
Bar graph data of serum PGE2 content are shown in
Figure 3. Serum PGE2 levels were similar at preopera-
tion, postoperation day 1 and after postoperation oral
feeding in the control group. Likewise, no significant dif-
ference was observed in serum PGE2 levels within sleeve
gastrectomy patients. Serum PGE2 levels were significantly
higher in sleeve gastrectomy patients at preoperation, post-
operation day 1 and after postoperation oral feeding when
compared to control group patients (Figure 3). Statistical
analysis was done by paired t-test.
Discussion
Polyunsaturated fatty acids regulate inflammatory re-
sponses through the production of eicosanoids includingsleeve gastrectomy group from preoperation up to
Sleeve gastrectomy group
F (n = 11) Preop (n = 10) Postop day 1 (n = 10) Po OF (n = 10)
7.5 ± 22.7 143.1 ± 44.5 114.7 ± 30.0 159.7 ± 25.0*,a
.4 ± 13.8 67.4 ± 27.2 53.9 ± 21.0 47.1 ± 16.3
.2 ± 6.4 5.6 ± 2.5 4.0 ± 1.2 4.2 ± 1.4
.1 ± 11.2 38.3 ± 14.8 33.8 ± 11.8 44. 6 ± 10.6
31 ± 0.11 0.47 ± 0.13 0.46 ± 0.12 0.31 ± 0.15**
.7 ± 12.6 28.2 ± 11.9 29.2 ± 5.6 42.0 ± 16.1**,a
39 ± 0.63 3.87 ± 0.85a 3.54 ± 0.66a 3.84 ± 1.50a
ation oral feeding; DGLA, Dihomo-gamma-linolenic acid; AA, Arachidonic acid;
omy group.






































































Preop   Postop D1 Po OF 
Figure 2 Distribution of measured polyunsaturated fatty acids in control and sleeve gastrectomy patients from preoperation up to
postoperation oral feeding. AA, Arachidonic acid; DGLA, Dihomo-gamma-linolenic acid; EPA, Eicosapentaenoic acid; DHA, Docosahexaenoic acid.
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http://www.lipidworld.com/content/13/1/62prostaglandins (PGs), thromboxanes (TXs) and leukotri-
enes (LTs) [2]. To our knowledge, this is the first study
evaluating early postoperative effects of LSG on plasma
PUFA levels. Plasma AA (C20:4n6) levels and AA/EPA
ratio were significantly increased in sleeve gastrectomy
patients after postoperation oral feeding compared to
postoperation day 1. The observed significant increase of
plasma AA levels following LSG may be due to in-
creased peripheral insulin sensitivity. In agreement with
previous studies [7,16] we have observed a significant re-
duction in insulin levels occurring very early at 4–5 daysfollowing sleeve gastrectomy with a significant reduction
in insulin resistance. It was recently shown that insulin
initiation therapy significantly increased plasma levels of
AA (C20:4n6) compared to before treatment levels in
T2DM patients [11]. Disturbed fatty acid metabolism is
an important feature of the insulin-resistant state [17].
Essential fatty acids are metabolized into more physiolo-
gically active compounds by introduction of further
double bonds by delta-5- and delta-6-desaturase en-
zymes [9]. Emerging evidence shows that delta-5 desa-































Figure 3 Prostaglandin E2 in control and sleeve gastrectomy
group from preoperation up to postoperation oral feeding.
*p < 0.05 sleeve gastrectomy group vs. control (the same day).
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sulin resistance [18]. The hepatic microsomal delta-6-
desaturation of LA and ALA was found to be depressed
in alloxan induced diabetic rats [19]. The observed en-
zymatic defect was corrected by insulin injection in
2 days [20].
High levels of saturated fatty acids and low amounts
of PUFAs are associated with obesity [21]. Omega-3
PUFA enriched diet increases expression of genes in-
volved in glucose transport [glucose transporter type 4
(GLUT-4)] and insulin signaling [insulin receptor sub-
strate 1 (IRS-1)], as well as genes involved in insulin sensi-
tivity [peroxisome proliferator-activated receptor gamma
(PPARγ)] [22]. In an insulin-resistant state, omega-3
PUFAs bind to the G-protein coupled receptor 120
(GPR120), resulting in reduced cytokine production from
inflammatory macrophages and improved signaling in adi-
pocytes, leading to a reduction in insulin resistance [23].
In this study, we have observed a significant increase in
AA/EPA ratio in sleeve gastrectomy patients after post-
operation oral feeding compared to preoperation levels.
This finding suggests that improved insulin sensitivity in
obese patients immediately after sleeve gastrectomy in not
related to changes in omega-3 PUFA levels.
Low serum EPA/AA ratio was recently reported in male
subjects with visceral obesity [4]. Likewise, an imbalance
of dietary long-chain PUFAs, especially high omega-6/
omega-3 PUFA ratio, was associated with increased risk
of cardiovascular disease [24]. We have observed that AA
(C20:4n6)/DHA(C22:6n3) ratio was significantly higher
in sleeve gastrectomy patients at preoperation, postopera-
tion day 1 and after postoperation oral feeding when com-
pared to control group subjects. The significant increase
of PGE2 levels and AA/DHA ratio in all performedmeasurements in the sleeve gastrectomy group patients
supports the presence of a proinflammatory state in obes-
ity. Competition between omega-6 and omega-3 fatty
acids occurs in the production of eicosanoids by stereo-
specific lipid-oxidizing enzymes cylooxygenase (COX) and
lipoxygenase (LOX) [25]. Docosahexaenoic acid (DHA,
C22:6n3) is a precursor of eicosanoids with less marked
inflammatory effect. On the other hand, AA is a precursor
of eicosanoids with definite inflammatory effect [26].
Hence, increased AA to DHA ratio indicates more precur-
sor for the synthesis of highly inflammatory eicosanoids.
As stated in the introduction of the manuscript, res-
toration of the first phase of insulin secretion and im-
proved insulin sensitivity in diabetic obese patients
immediately after sleeve gastrectomy, before any weight
loss, seem to be related to hormonal changes of possible
gastric origin and is neither meal- nor weight-change-
related [12]. Significantly increased AA levels in sleeve
gastrectomy patients after postoperation oral feeding
may play a constructive role in the observed improved
insulin sensitivity in sleeve gastrectomy patients. It was
previously observed that patients with type 2 diabetes
mellitus have low AA content in their plasma phospho-
lipid fraction and it was suggested that AA deficiency
may predispose humans to develop T2DM [27]. In sup-
port of these findings it was recently demonstrated that
insulin analog initiation therapy in T2DM patients in-
creased AA in human plasma (11). The role of AA as a
possible endogenous anti-diabetic molecule is discussed
comprehensively in a recent review [28].
Limitation of our study include: 1) the study covers a
small cohort; 2) the study has a nonrandomized design
because patients were assigned to either group according
to clinical criteria; 3) The study population included an
unequal percentage of male patients. However, the limi-
tation of gender distribution has been minimized by
matching the control group similarly.
In summary, we have observed a significant decrease in
insulin and HOMA IR levels in sleeve gastrectomy pa-
tients after postoperation oral feeding compared to preo-
peration. This was accompanied by significantly increased
plasma AA levels. The significant increase in PGE2 levels
and AA/DHA ratio in sleeve gastrectomy group patients
also confirms the presence of a proinflammatory state in
obesity.Abbreviations
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